Transcatheter Ventricular Septal Defect Closure with Lifetech™ Konar-MF Occluder in Infants Under 10 kg with Only Using Venous Access.
Infant
KONAR-multifunctional occluder
Transcatheter intervention
Ventricular septal defect
Journal
Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849
Informations de publication
Date de publication:
11 Dec 2023
11 Dec 2023
Historique:
received:
19
08
2023
accepted:
09
11
2023
medline:
12
12
2023
pubmed:
12
12
2023
entrez:
11
12
2023
Statut:
aheadofprint
Résumé
Transcatheter closure of VSD remains a complex procedure in infants with technical challenges and carries the risk of significant complications, due to its complex anatomical morphology and closed proximity to the atrioventricular valves and the conduction system. In this article, we presented transcatheter VSD closure in infants under 10 kg using the Lifetech Konar-MF device via only venous route without TEE guidance and arterial access. Between January 2021 and May 2023, a total of 34 patients weighing less than 10 kg who underwent transcatheter VSD closure antegradely with Lifetech™ Konar-Multifunctional (MF) occluder were included in the study. The mean age of the patients was 8.1 (3.5-35) months. Average weight was 6.5 kg (range 4.5-10 kg). VSD was perimembranous in 27 patients (79.4%). Successful device placement was achieved in all 34 patients. However, device embolization occurred in three patients. One of the patients was successfully implanted with a one size larger device, the surgical closure was performed other two cases. TR occurred in seven patients (20.6%) after releasing devices. None of the patients developed complete heart block. Right bundle branch block developed in two patients. Residual shunt was observed in 9 patients (six small, two moderate, and one large). During follow-up, residual shunt disappeared in six of these patients and only mild residual shunt remained in the other four patients which have not required any further intervention. Transcatheter closure of VSD with Lifetech Konar-MF device is safe and effective in infants less than 10 kg via only venous access with a high success rate and low complication rate. In these patients, transcatheter VSD closure can be performed by excluding the risk of complications that may occur due to AV loop formation, arterial intervention, endotracheal intubation and TEE use.
Identifiants
pubmed: 38081968
doi: 10.1007/s00246-023-03350-3
pii: 10.1007/s00246-023-03350-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Hoffman J, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39(12):1890–1900
doi: 10.1016/S0735-1097(02)01886-7
pubmed: 12084585
Morray BH (2019) Ventricular septal defect closure devices, techniques, and outcomes. Interv Cardiol Clin 8(1):1–10
pubmed: 30449417
Zhao LJ, Han B, Zhang JJ, Yi YC, Jiang DD, Lyu JL (2018) Transcatheter closure of congenital perimembranous ventricular septal defect using the Amplatzer duct occluder 2. Cardiol Young 28(3):447–453
doi: 10.1017/S1047951117002396
pubmed: 29233213
Santhanam H, Yang L, Chen Z, Tai BC, Rajgor DD, Quek SC (2018) A meta-analysis of transcatheter device closure of perimembranous ventricular septal defect. Int J Cardiol 254:75–83
doi: 10.1016/j.ijcard.2017.12.011
pubmed: 29273241
Hong ZN, Chen Q, Huang LQ, Cao H (2019) A meta-analysis of per- ventricular device closure of perimembranous ventricular septal defect. J Cardiothorac Surg 14(1):119
doi: 10.1186/s13019-019-0936-5
pubmed: 31248430
pmcid: 6598304
Yang L, Tai BC, Khin LW, Quek SC (2014) A systematic review on the efficacy and safety of transcatheter device closure of ventricular septal defects (VSD). J Interv Cardiol 27(3):260–272
doi: 10.1111/joic.12121
pubmed: 24773223
Haddad RN, Daou L, Saliba Z (2019) Device closure of perimembranous ventricular septal defect: choosing between amplatzer occluders. Front Pediatr 7:300
doi: 10.3389/fped.2019.00300
pubmed: 31475122
pmcid: 6707042
Holzer R, de Giovanni J, Walsh KP, Tometzki A, Goh T, Hakim F, Zabal C, de Lezo JS, Cao QL, Hijazi ZM (2006) Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry. Catheter Cardiovasc Interv 68(4):620–628
doi: 10.1002/ccd.20659
pubmed: 16969878
Zuo J, Xie J, Yi W, Yang J, Zhang J, Li J, Yi D (2010) Results of transcatheter closure of perimembranous ventricular septal defect. Am J Cardiol 106(7):1034–1037
doi: 10.1016/j.amjcard.2010.05.040
pubmed: 20854970
Hammon JW Jr (1995) Myocardial protection in the immature heart. Ann Thorac Surg 60(3):839–842
doi: 10.1016/0003-4975(95)00573-4
pubmed: 7677543
Qin Y, Chen J, Zhao X, Liao D, Mu R, Wang S, Wu H, Guo H (2008) Transcatheter closure of perimembranous ventricular septal defect using a modified double-disk occluder. Am J Cardiol 101(12):1781–1786
doi: 10.1016/j.amjcard.2008.02.069
pubmed: 18549859
Saurav A, Kaushik M, Mahesh Alla V, White MD, Satpathy R, Lanspa T, Mooss AN, DelCore MG (2015) Comparison of percutaneous device closure versus surgical closure of peri-membranous ven- tricular septal defects: a systematic review and meta-analysis. Catheter Cardiovasc Interv 86(6):1048–1056
doi: 10.1002/ccd.26097
pubmed: 26257085
Lock JE, Block PC, McKay RG, Baim DS, Keane JF (1988) Transcatheter closure of ventricular septal defects. Circulation 78(2):361–368
doi: 10.1161/01.CIR.78.2.361
pubmed: 3396173
Vitiello R, McCrindle BW, Nykanen D, Freedom RM, Benson LN (1998) Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol 32(5):1433–1440
doi: 10.1016/S0735-1097(98)00396-9
pubmed: 9809959
Tadphale S, Yohannan T, Kauffmann T, Maller V, Agrawal V, Lloyd H, Waller BR, Sathanandam S (2020) Accessing femoral arteries less than 3 mm in diameter is associated with increased incidence of loss of pulse following cardiac catheterization in infants. Pediatr Cardiol 41(5):1058–1066
doi: 10.1007/s00246-020-02357-4
pubmed: 32367307
Kulkarni S, Naidu R (2006) Vascular ultrasound imaging to study immediate postcatheterization vascular complications in children. Catheter Cardiovasc Interv 68(3):450–455
doi: 10.1002/ccd.20884
pubmed: 16892445
Diab KA, Cao QL, Mora BN, Hijazi ZM (2007) Device closure of muscular ventricular septal defects in infants less than one year of age using the Amplatzer devices: feasibility and outcome. Catheter Cardiovasc Interv 70(1):90–97
doi: 10.1002/ccd.21142
pubmed: 17585388
Arora R, Trehan V, Kumar A, Kalra GS, Nigam M (2003) Transcatheter closure of congenital ventricular septal defects: experience with various devices. J Interv Cardiol 16(1):83–91
doi: 10.1046/j.1540-8183.2003.08006.x
pubmed: 12664821
Zhao PJ, Yu ZQ, Gao W, Li F, Fu LJ, Liu TL, Li Y, Zhang YQ, Huang MR, Guo Y (2012) Efficacy of the transcatheter closure of perimembranous and muscular ventricular septal defects with the Amplatzer duct occluder II. Zhonghua Xin Xue Guan Bing Za Zhi 40(10):817–820
pubmed: 23302666
Damsky Barbosa J, Alonso J, Ferrín L, Rivarola M, Lucini V et al (2019) Endovascular VSD closure with lifetech KONAR-multifunctional occluder- novel device. J Struct Heart Dis 5(6):237–247
Tanidir IC, Baspinar O, Saygi M, Kervancioglu M, Guzeltas A, Odemis E (2020) Use of Lifetech™ Konar-MF, a device for both perimembranous and muscular ventricular septal defects: a multicentre study. Int J Cardiol 310:43–50
doi: 10.1016/j.ijcard.2020.02.056
pubmed: 32122701
Mukherji A, Chattopadhyay A, Ghosh S, Mohapatra SK, De A, Singhi AK (2020) Novel use of Konar-multifunctional occluder. Cardiol Young 30(11):1722–1727
doi: 10.1017/S1047951120002668
pubmed: 32856582
Li H, Shi Y, Zhang S, Ren Y, Rong X, Wang Z, Xia T, Wu T, Xu H, Yan Y, Zhan Y, Chu M, Wu R (2019) Short- and medium-term follow-up of transcatheter closure of perimembranous ventricular septal defects. BMC Cardiovasc Disord 19(1):222
doi: 10.1186/s12872-019-1188-y
pubmed: 31619172
pmcid: 6794751
Yildiz K, Narin N, Ozdemir R, Oksuz S, Demircan T, Bagli S, Aktas R, Nur Kecici R, Karadeniz C (2023) Closure of transcatheter ventricular septal defect using LifetechTM Konar-MF Occluder in children weighing less than 10 kilograms: mid-term results, a tertiary single center experience. Eur Rev Med Pharmacol Sci 27(9):4053–4059
pubmed: 37203829
Roy M, Gangopadhyay D, Goyal N, Murthy S, Nandi D, Bandyopadhyay B, Dutta J (2022) Transcatheter closure of ventricular septal defects in children less than 10 kg: experience from a tertiary care referral hospital in Eastern India. Cardiol Young 32(1):48–54
doi: 10.1017/S1047951121001578
pubmed: 33998424
Mathur SK, Singh P (2009) Transoesophageal echocardiography related complications. Indian J Anaesth 53(5):567–574
pubmed: 20640107
pmcid: 2900089
Min JK, Spencer KT, Furlong KT, DeCara JM, Sugeng L, Ward RP, Lang RM (2005) Clinical features of complications from transesophageal echocardiography: a single-center case series of 10,000 consecutive examinations. J Am Soc Echocardiogr 18(9):925–929
doi: 10.1016/j.echo.2005.01.034
pubmed: 16153515
Wang S, Ouyang W, Liu Y, Zhang F, Guo G, Zhao G, Pan X (2018) Transcatheter perimembranous ventricular septal defect closure under transthoracic echocardiographic guidance without fluoroscopy. J Thorac Dis 10(9):5222–5231
doi: 10.21037/jtd.2018.08.03
pubmed: 30416769
pmcid: 6196205
Carminati M, Butera G, Chessa M, De Giovanni J, Fisher G, Gewillig M, Peuster M, Piechaud JF, Santoro G, Sievert H, Spadoni I, Walsh K (2007) Investigators of the European VSD Registry. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J 28(19):2361–2368
doi: 10.1093/eurheartj/ehm314
pubmed: 17684082
Kuswiyanto RB, Gunawijaya E, Djer MM, Noormanto RMA et al (2022) Transcatheter closure of perimembranous ventricular septal defect using the lifetech Konar-multi functional occluder: early to midterm results of the indonesian multicenter study. Glob Heart 17(1):15
doi: 10.5334/gh.1106
pubmed: 35342698
pmcid: 8877696
Haddad RN, Daou LS, Saliba ZS (2020) Percutaneous closure of restrictive-type perimembranous ventricular septal defect using the new KONAR multifunctional occluder: midterm outcomes of the first middle-eastern experience. Catheter Cardiovasc Interv 96(3):295–302
doi: 10.1002/ccd.28678